Technical Analysis for NBRV - Nabriva Therapeutics AG

Grade Last Price % Change Price Change
grade F 1.84 -3.16% -0.06
NBRV closed down 3.16 percent on Monday, November 18, 2019, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NBRV trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -3.16%
Bearish Engulfing Bearish -7.54%
Fell Below 50 DMA Bearish -7.54%
Expansion Pivot Sell Setup Bearish Swing Setup -7.54%
Upper Bollinger Band Touch Strength -7.54%

Older signals for NBRV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It also develops BC-7013, a topical pleuromutilin antibiotic, which has completed a Phase 1 clinical trial. Nabriva Therapeutics AG is based in Vienna, Austria.
Chemistry Pharmaceutical Industry Chemical Compounds Organic Compounds Antibiotics Alcohols Antibiotic Infections Skin And Skin Structure Infections Pneumonia Community Acquired Bacterial Pneumonia Thioethers
Is NBRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.27
52 Week Low 1.12
Average Volume 943,318
200-Day Moving Average 2.2796
50-Day Moving Average 2.0217
20-Day Moving Average 1.939
10-Day Moving Average 1.982
Average True Range 0.1223
ADX 14.33
+DI 21.6955
-DI 24.7665
Chandelier Exit (Long, 3 ATRs ) 1.8631
Chandelier Exit (Short, 3 ATRs ) 2.0969
Upper Bollinger Band 2.1093
Lower Bollinger Band 1.7687
Percent B (%b) 0.21
BandWidth 17.565756
MACD Line -0.0044
MACD Signal Line -0.0017
MACD Histogram -0.0027
Fundamentals Value
Market Cap 49.38 Million
Num Shares 26.8 Million
EPS -11.49
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 24.71
Price-to-Book 3.00
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.96
Resistance 3 (R3) 1.97 1.93 1.94
Resistance 2 (R2) 1.93 1.90 1.93 1.93
Resistance 1 (R1) 1.89 1.88 1.87 1.88 1.93
Pivot Point 1.85 1.85 1.85 1.85 1.85
Support 1 (S1) 1.81 1.82 1.79 1.80 1.75
Support 2 (S2) 1.77 1.80 1.77 1.75
Support 3 (S3) 1.73 1.77 1.74
Support 4 (S4) 1.72